Management and prognosis of atrial fibrillation in the diabetic patient

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Management and prognosis of atrial fibrillation in the diabetic patient. / Pallisgaard, Jannik Langtved; Lindhardt, Tommi Bo; Olesen, Jonas Bjerring; Hansen, Morten Lock; Carlson, Nicholas; Gislason, Gunnar Hilmar.

I: Expert Review of Cardiovascular Therapy, Bind 13, Nr. 6, 06.2015, s. 643-51.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Pallisgaard, JL, Lindhardt, TB, Olesen, JB, Hansen, ML, Carlson, N & Gislason, GH 2015, 'Management and prognosis of atrial fibrillation in the diabetic patient', Expert Review of Cardiovascular Therapy, bind 13, nr. 6, s. 643-51. https://doi.org/10.1586/14779072.2015.1043892

APA

Pallisgaard, J. L., Lindhardt, T. B., Olesen, J. B., Hansen, M. L., Carlson, N., & Gislason, G. H. (2015). Management and prognosis of atrial fibrillation in the diabetic patient. Expert Review of Cardiovascular Therapy, 13(6), 643-51. https://doi.org/10.1586/14779072.2015.1043892

Vancouver

Pallisgaard JL, Lindhardt TB, Olesen JB, Hansen ML, Carlson N, Gislason GH. Management and prognosis of atrial fibrillation in the diabetic patient. Expert Review of Cardiovascular Therapy. 2015 jun.;13(6):643-51. https://doi.org/10.1586/14779072.2015.1043892

Author

Pallisgaard, Jannik Langtved ; Lindhardt, Tommi Bo ; Olesen, Jonas Bjerring ; Hansen, Morten Lock ; Carlson, Nicholas ; Gislason, Gunnar Hilmar. / Management and prognosis of atrial fibrillation in the diabetic patient. I: Expert Review of Cardiovascular Therapy. 2015 ; Bind 13, Nr. 6. s. 643-51.

Bibtex

@article{546e23f383394d68a2ef93664b2bf795,

title = "Management and prognosis of atrial fibrillation in the diabetic patient",

abstract = "The global burden of atrial fibrillation and diabetes mellitus (diabetes) is considerable, and prevalence rates are increasing. Diabetes is associated with an increased risk of developing atrial fibrillation; however, diabetes also influences the management and prognosis of atrial fibrillation. In the following article, the authors describe the association between diabetes and atrial fibrillation; specifically, the significance of diabetes on the risk of atrial fibrillation, ischemic stroke and bleeding complications associated with anticoagulation. In addition, the authors evaluate the risks and outcomes of heart failure and the success rates of both ablation and cardioversion in atrial fibrillation patients with diabetes. Finally, this article describes the association of HbA1c levels with the management and prognosis of atrial fibrillation patients.",

keywords = "Anticoagulants, Atrial Fibrillation, Cost of Illness, Diabetes Complications, Diabetes Mellitus, Hemoglobin A, Glycosylated, Hemorrhage, Humans, Prevalence, Prognosis, Stroke",

author = "Pallisgaard, {Jannik Langtved} and Lindhardt, {Tommi Bo} and Olesen, {Jonas Bjerring} and Hansen, {Morten Lock} and Nicholas Carlson and Gislason, {Gunnar Hilmar}",

year = "2015",

month = jun,

doi = "10.1586/14779072.2015.1043892",

language = "English",

volume = "13",

pages = "643--51",

journal = "Expert Review of Cardiovascular Therapy",

issn = "1477-9072",

publisher = "Taylor & Francis",

number = "6",

}

RIS

TY - JOUR

T1 - Management and prognosis of atrial fibrillation in the diabetic patient

AU - Pallisgaard, Jannik Langtved

AU - Lindhardt, Tommi Bo

AU - Olesen, Jonas Bjerring

AU - Hansen, Morten Lock

AU - Carlson, Nicholas

AU - Gislason, Gunnar Hilmar

PY - 2015/6

Y1 - 2015/6

N2 - The global burden of atrial fibrillation and diabetes mellitus (diabetes) is considerable, and prevalence rates are increasing. Diabetes is associated with an increased risk of developing atrial fibrillation; however, diabetes also influences the management and prognosis of atrial fibrillation. In the following article, the authors describe the association between diabetes and atrial fibrillation; specifically, the significance of diabetes on the risk of atrial fibrillation, ischemic stroke and bleeding complications associated with anticoagulation. In addition, the authors evaluate the risks and outcomes of heart failure and the success rates of both ablation and cardioversion in atrial fibrillation patients with diabetes. Finally, this article describes the association of HbA1c levels with the management and prognosis of atrial fibrillation patients.

AB - The global burden of atrial fibrillation and diabetes mellitus (diabetes) is considerable, and prevalence rates are increasing. Diabetes is associated with an increased risk of developing atrial fibrillation; however, diabetes also influences the management and prognosis of atrial fibrillation. In the following article, the authors describe the association between diabetes and atrial fibrillation; specifically, the significance of diabetes on the risk of atrial fibrillation, ischemic stroke and bleeding complications associated with anticoagulation. In addition, the authors evaluate the risks and outcomes of heart failure and the success rates of both ablation and cardioversion in atrial fibrillation patients with diabetes. Finally, this article describes the association of HbA1c levels with the management and prognosis of atrial fibrillation patients.

KW - Anticoagulants

KW - Atrial Fibrillation

KW - Cost of Illness

KW - Diabetes Complications

KW - Diabetes Mellitus

KW - Hemoglobin A, Glycosylated

KW - Hemorrhage

KW - Humans

KW - Prevalence

KW - Prognosis

KW - Stroke

U2 - 10.1586/14779072.2015.1043892

DO - 10.1586/14779072.2015.1043892

M3 - Journal article

C2 - 26000562

VL - 13

SP - 643

EP - 651

JO - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

SN - 1477-9072

IS - 6

ER -

ID: 160476619